Author Topic: (Abst.) Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy  (Read 13 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest



From PubMed (December 22, 2023)—“Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy”:


https://pubmed.ncbi.nlm.nih.gov/38124108/
« Last Edit: December 22, 2023, 02:27:04 pm by agate »
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
163 Views
Last post April 07, 2016, 02:12:24 pm
by agate
0 Replies
91 Views
Last post June 12, 2018, 09:18:55 pm
by agate
0 Replies
134 Views
Last post August 03, 2018, 09:29:58 pm
by agate
0 Replies
107 Views
Last post December 17, 2018, 10:02:37 am
by agate
0 Replies
43 Views
Last post January 25, 2022, 09:03:25 pm
by agate